All Stories

  1. Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study
  2. Essentials for a successful registry: valid data, the right questions and timely execution
  3. Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma
  4. Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland
  5. Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinoma
  6. Optimizing case reports and case series: guidance on how to improve quality
  7. Change over time in the rates of adverse events in patients receiving systemic therapy for psoriasis: A cohort study
  8. Big data in small diseases: the case of necrotizing soft-tissue infections
  9. Systematic reviews: let's keep them trustworthy
  10. Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study
  11. Report from the first European Dermato-Epidemiology Network forum
  12. Study of Cognitive Function in Children Treated with Propranolol for Infantile Hemangioma
  13. Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry
  14. Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries
  15. Drug Survival Analysis Is Not a Good Method for Assessing the Safety or Effectiveness of Systemic Therapies in Psoriasis
  16. Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts
  17. El análisis de supervivencia no es un buen método para evaluar la seguridad o la efectividad de los tratamientos sistémicos en psoriasis
  18. Case reports in dermatology: loved by clinicians, loathed by editors, and occasionally important
  19. Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti–tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries
  20. Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry
  21. Incidencia y mortalidad del cáncer cutáneo en España: revisión sistemática y metaanálisis
  22. Skin Cancer Incidence and Mortality in Spain: A Systematic Review and Meta-Analysis
  23. Censo de los centros que realizan cirugía de Mohs en España y descripción de su actividad: estudio de factibilidad para el registro de cirugía de Mohs de la FAEDV
  24. CARE guidelines and how to improve case reporting. Does one size fit all?
  25. Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time
  26. Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort
  27. Descripción de los pacientes intervenidos mediante cirugía de Mohs en España. Datos basales del registro español de cirugía de Mohs (REGESMOHS)
  28. Prioritization of therapy uncertainties in congenital ichthyosis: results from a Priority Setting Partnership
  29. Dispersión en la atención médica de los pacientes con ictiosis
  30. Riesgo de reactivación de hepatitis B pasada en pacientes con psoriasis tratados con biológicos. Análisis retrospectivo de 20 casos. Registro de BIOBADADERM
  31. Fragomented Health Care Delivery in Ichthyosis
  32. Modalidades de fototerapia para el tratamiento de la dermatitis atópica: revisión sistemática de la literatura
  33. La unidad de investigación de la Fundación Academia Española de Dermatología y Venereología
  34. Research Unit of the Spanish Academy of Dermatology and Venerology Foundation
  35. Phototherapy in Atopic Dermatitis: A Systematic Review of the Literature
  36. Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: A cross-sectional study in clinical practice
  37. Treatment of hidradenitis suppurativa with intralesional photodynamic therapy using a laser diode attached to an optical cable: a promising new approach
  38. Current dystrophic epidermolysis bullosa research does not match research needs perceived by patients and clinicians
  39. Descripción de los ingresos dermatológicos en España (2005-2010). Datos de base poblacional del conjunto mínimo básico de datos
  40. Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry
  41. The Use of Systematic Reviews in Clinical Trials and Narrative Reviews in Dermatology: Is the Best Evidence Being Used?
  42. Empleo de las revisiones sistemáticas en ensayos clínicos y revisiones narrativas en dermatología: ¿se usa la mejor evidencia disponible?
  43. Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry
  44. Prevalence of Dystrophic Epidermolysis Bullosa in Spain: A Population-Based Study Using the 3-Source Capture–Recapture Method. Evidence of a Need for Improvement in Care
  45. Estudio de calidad de vida en pacientes con lupus eritematoso cutáneo
  46. A Quality-of-Life Study of Cutaneous Lupus Erythematosus
  47. A systematic review of clinical trials of treatments for the congenital ichthyoses, excluding ichthyosis vulgaris
  48. Utilidad de las revisiones del Cochrane Skin Group para la práctica clínica
  49. Usefulness of Cochrane Skin Group Reviews for Clinical Practice
  50. Systemic psoriasis therapy shows high between-country variation: a sign of unwarranted variation? Cross-sectional analysis of baseline data from the PSONET registries
  51. Impact of STROBE Statement Publication on Quality of Observational Study Reporting: Interrupted Time Series versus Before-After Analysis
  52. Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry
  53. Prioritization of therapy uncertainties in Dystrophic Epidermolysis Bullosa: where should research direct to? an example of priority setting partnership in very rare disorders
  54. Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry
  55. Réplica a: « Productos de higiene, antisepsia y eccema de manos: no solo etiología irritativa»
  56. Response to: «Hand Eczema Due to Hygiene and Antisepsis Products: Not Only an Irritative Etiology»
  57. Photodynamic therapy with intralesional photosensitizer and laser beam application: An alternative treatment for nodular basal cell carcinoma
  58. Prevalence of autosomal recessive congenital ichthyosis: A population-based study using the capture-recapture method in Spain
  59. Updated systematic review of randomized controlled trials of treatments for inherited forms of epidermolysis bullosa
  60. Utilidad de los registros dermatológicos: ¿qué han aportado y qué aportarán?
  61. Anestesia tumescente en cirugía dermatológica
  62. Tumescent Anesthesia in Dermatologic Surgery
  63. Productos de higiene y antisepsia de manos: su empleo y relación con el eccema de manos en los profesionales sanitarios
  64. Risk of Serious Adverse Events Associated With Biologic and Nonbiologic Psoriasis Systemic Therapy
  65. Challenges for Synthesising Data in a Network of Registries for Systemic Psoriasis Therapies
  66. Pruritic Urticarial Skin Lesions —Quiz Case
  67. ¿Quién financia la investigación de los dermatólogos españoles? Análisis del año 2008 y comparación con otros grupos
  68. Who Funds Research by Spanish Dermatologists? Comparative Analysis of Articles Published in 2008
  69. Pioderma gangrenoso con afectación pulmonar: caso clínico y revisión de la literatura
  70. Reproducibilidad del diagnóstico dermatológico de onicomicosis en al ámbito clínico
  71. BIOBADADERM: registro español de acontecimientos adversos de terapias biológicas en Dermatología. Primer informe
  72. Chloroquine-induced myopathy
  73. Clinical diagnosis of toenail onychomycosis is possible in some patients: cross-sectional diagnostic study and development of a diagnostic rule
  74. Evolución de la investigación clínica publicada por los dermatólogos españoles y comparación con otros grupos en 2008
  75. Geoffrey Rose y cómo estimular la investigación clínica en la Dermatología española
  76. Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
  77. Ulceración nasal
  78. Inappropriate References in “Oral Leukoplakia: Clinical, Histopathologic, and Molecular Features and Therapeutic Approach” to the Sudbø Fraud
  79. Citas inadecuadas en «La leucoplasia oral: Definición de parámetros clínicos, histopatológicos y moleculares y actitud terapéutica» referentes al fraude Sudbo
  80. Nasal Ulceration
  81. Aspectos prácticos de la quinacrina como tratamiento del lupus eritematoso cutáneo: serie de casos
  82. Utilidad de las biopsias palmoplantares en lesiones hiperqueratósicas y vesiculopustulosas. Estudio transversal
  83. Geoffrey Rose and How to Foster Clinical Research in Spanish Dermatology
  84. Quinacrine in the Treatment of Cutaneous Lupus Erythematosus: Practical Aspects and a Case Series
  85. Clinical Research Publication by Spanish Dermatologists Over Time and in Comparison With Other Research Groups in 2008
  86. Generalised tetanus in a patient with a chronic ulcerated skin lesion
  87. Introducción a la investigación clínica en Dermatología. Un nexo entre clínica e investigación
  88. Introduction to Clinical Research in Dermatology: The Link Between Clinical Practice and Research
  89. Observer agreement in toenail disorders: implications for diagnosis and clinical research
  90. Actitud de los dermatólogos ante lesiones sugestivas de onicomicosis en los pies
  91. Dermatologists’ Approach to Lesions Suggestive of Onychomycosis of the Toenails
  92. Estructura social de la Dermatología
  93. Plantar keratoderma as a presenting sign of pancreatic adenocarcinoma
  94. The Social Structure of Dermatology: Between the Medieval and the Early Modern
  95. Minimal phototoxic dose determination at 72 h vs. 120 h
  96. Training and Experience of Peer Reviewers: Is Being a “Good Reviewer” a Persistent Quality?
  97. Inmunización contra la hepatitis vírica: una recomendación obligada en las consultas por enfermedades de transmisión sexual
  98. Lymphomatoid contact dermatitis induced by gold earrings
  99. Intervalos de confianza, pes y farolas
  100. Grover’s Disease in a Patient Undergoing Peritoneal Dialysis with Resolution After Renal Transplant
  101. Lichen Aureus Induced By Interferon-Alpha plus Ribavirin
  102. Confidence Intervals, “P”s and Lights
  103. Immunization Against Viral Hepatitis: An Obligatory Recommendation in Consults for Sexually Transmitted Diseases
  104. Bullous pemphigoid triggered by influenza vaccination? Ecological study in Galicia, Spain
  105. Scalp necrosis and ulceration secondary to heroin injection
  106. Sustitución de corticoterapia sistémica por tópica en pacientes con penfigoide ampolloso generalizado y iatrogenia esteroidea grave
  107. Osificación bilateral del cartílago auricular
  108. Chronic leg ulcers and basal cell carcinoma
  109. Acute Generalized Exanthematous Pustulosis due to Pseudoephedrine with Positive Patch Test
  110. Progressive Nodular Histiocytoma Associated with Thrombocytopenia with Absent Radii (TAR Syndrome) and Angiofibromas
  111. Síndrome de De Sanctis-Cacchione
  112. Toxic epidermal necrolysis secondary to timolol, dorzolamide, and latanoprost eyedrops
  113. Estudio comparativo del tratamiento de la psoriasis en placas con baño de PUVA y UVB de banda estrecha (311 nm)
  114. Pseudoangiosarcomatous Squamous Cell Carcinoma of Skin Arising Adjacent to Decubitus Ulcers
  115. Sepsis Associated with Dermatologic Hospitalization Is not the Cause of High Mortality of Bullous Pemphigoid in Europe
  116. Three More Learning Points
  117. Telangiectasia unilateral nevoide como signo de embarazo.
  118. Topical Tacrolimus in Cutaneous Lesions of Dermatomyositis: Lack of Effect in Side-by-Side Comparison in Five Patients
  119. Coexistence of acquired localized hypertrichosis and lipoatrophy after lupus panniculitis
  120. Systemic photosensitivity to quinapril
  121. Rifampicin/pyrazinamide therapy should not be used for latent tuberculosis infection
  122. Transient verrucous hyperplasia after toxic epidermal necrolysis
  123. Estudio de las dermatofitosis en el área del Complejo Hospitalario de Pontevedra (2000-2002) y comparación con el período enero 1991-mayo 1993
  124. Mucinosis pretibial como manifestación de dermatitis de estasis
  125. Inpatient dermatology: characteristics of patients and admissions in a Spanish hospital1
  126. Sporotrichoid Spread of Mycobacterium Chelonae in a Presumably Immunocompetent Patient
  127. Generalized Bullous Fixed Drug Eruption after Influenza Vaccination, Simulating Bullous Pemphigoid
  128. Disseminated Superficial Porokeratosis with Mucosal Involvement
  129. Abdominal nodules as a presentation of obstruction of the inferior vena cava and factor V Leiden mutation
  130. Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome
  131. Acquired cutaneous lymphangiectasia in a patient with cirrhotic ascites
  132. Acquired cutaneous lymphangiectasia in a patient with cirrhotic ascites
  133. Disseminated Punctate Intraepidermal Haemorrhage: A Widespread Counterpart of Black Heel
  134. Acrochordons Are Not a Component of the Birt-Hogg-Dubé Syndrome
  135. Infantile Pyramidal Protrusion as a Manifestation of Lichen Sclerosus et Atrophicus
  136. Subcutaneous sarcoidosis worsened by cyclosporin treatment for pyoderma gangrenosum
  137. Acute Respiratory Distress Syndrome and Generalized Pustular Psoriasis: Another Case Report
  138. Pleomorphic fibroma of the skin, a form of sclerotic fibroma: an immunohistochemical study
  139. Extensive bullous lichen sclerosus et atrophicus unresponsive to hydroxychloroquine
  140. Follicular Accentuation of Leukocytoclastic Vasculitis in an HIV-lnfected Patient